Infants and children below 16 years of age were exempted from being inoculated with the COVID-19 vaccine because they were not involved in the clinical trials says an Associate Professor at the Faculty of Pharmacy, University of Lagos, Dr. Arinola Joda which is just like what professor Oyewole Tomori a renowned virologist and former Vice-Chancellor of the Redeemer’s University Nigeria mentioned, that nobody is sure how the vaccine may react on the fetus.
In an interview with a Newsman, Joda squashed the claim that the trials focused only on privileged few. According to her, “It is not a matter of privilege. Adults are much more susceptible to the virus. Children have been so far spared and this can be seen from various studies carried out.
“The proportion of children affected is small. It, therefore, makes sense that the focus should not be on children when carrying out clinical trials. It is expedient not to expose them to the vaccines at this time.
“However, I am aware that one of the vaccine-producing companies is currently running a trial that involves children. When the results are ready, they will be able to update the guidance,” she said.
Continuing, the expert disclosed that only two COVID-19 vaccines – Pfizer-BioNTech and Moderna are currently authorized for the prevention of the virus.
“ThePfizer-BioNTech vaccine requires two injections given 21 days apart and is targeted at people aged 16 and above. Moderna vaccine, on the other hand, is for people age 18 and older. It requires two injections given 28 days apart.
Speaking in the same vein, a renowned professor of virology and former Vice-Chancellor of the Redeemer’s University Nigeria, Oyewole Tomori, also said that children and pregnant women were exempted from the trial based on the spectrum of the virus.
According to him, “It is hard to tell how they will react, hence the need to look at the spectrum of the infection – those who are affected and age groups. On the strength of that, children and pregnant women are not usually included.
“It is only when it works in other age groups that we can subsequently begin to look at them. We have to be very careful because the virus is something new and we don’t know what may happen,” he said.
He noted that Children’s immunity cannot outweigh that of the adult. We want to see how such a vaccine behaves first in adults. It is only when you get a good response that you can proceed to the next age group.